Snapshot · Russell 3000 · generated 2026-10-17 22:04 UTC
PCRX — Pacira BioSciences, Inc.
UNDERVALUED (MOS +55.8%) · Quality 59/100
Price
36.34
Intrinsic value
82.25
Margin of safety
+55.8%
Implied growth (reverse DCF)
+0.1%
model assumes +13.5%
Value Score
28.9
Quality
59
Psychology
-73.4
Discovery
8
price/volume attention only
Moat score
21.2
erosion: none
Value Score: top 48% of Russell 3000 · Quality: top 39%
Open the interactive Deep Dive for PCRX →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/PCRX - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
Is PCRX undervalued?
As of 2026-10-17, PCRX trades at 36.34 against a computed intrinsic value of 82.25 (+55.8% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.
What is Pacira BioSciences, Inc.'s Value Score?
Pacira BioSciences, Inc.'s Value Score is 28.9 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.